Jenburkt Pharmaceuticals Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1074 as of 05 May 15:30 . The p/e ratio of Jenburkt Pharmaceuticals Ltd changed from 13.9 to 11.7 over 5 quarters. This represents a CAGR of -12.88% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Jenburkt Pharmaceuticals Ltd changed from ₹ 446.49 crore to ₹ 304.27 crore over 5 quarters. This represents a CAGR of -26.42% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 44.84 crore as compare to the Sep '25 revenue of ₹ 47.64 crore. This represent the decline of -5.88% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The ebitda of Jenburkt Pharmaceuticals Ltd for the Dec '25 is ₹ 9.24 crore as compare to the Sep '25 ebitda of ₹ 15.18 crore. This represent the decline of -39.13% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The net profit of Jenburkt Pharmaceuticals Ltd changed from ₹ 6.51 crore to ₹ 5.93 crore over 7 quarters. This represents a CAGR of -5.19% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The dividend payout of Jenburkt Pharmaceuticals Ltd changed from 24.76 % to 25.97 % over 5 quarters. This represents a CAGR of 3.89% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Jenburkt Pharmaceuticals Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Jenburkt Pharmaceuticals Ltd or Procter & Gamble Health Ltd?

Market cap of Jenburkt Pharmaceuticals Ltd is 459 Cr while Market cap of Procter & Gamble Health Ltd is 8,549 Cr

What are the key factors driving the stock performance of Jenburkt Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

The stock performance of Jenburkt Pharmaceuticals Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jenburkt Pharmaceuticals Ltd and Procter & Gamble Health Ltd?

As of May 5, 2026, the Jenburkt Pharmaceuticals Ltd stock price is INR ₹1042.2. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5150.25.

How do dividend payouts of Jenburkt Pharmaceuticals Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Jenburkt Pharmaceuticals Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.